Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Intermittently Scanned Continuous Glucose Monitoring in the Diagnosis of Maturity-onset Diabetes of the Young (MODY) Patients

NCT05918484 is registered in ClinicalTrials.gov with Castilla-La Mancha Health Service as lead sponsor.

NCT NCT05918484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05918484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Intermittently Scanned Continuous Glucose Monitoring in the Diagnosis of Maturity-onset Diabetes of the Young (MODY) Patients
Lead sponsor
Castilla-La Mancha Health Service
Phase
Observational
Overall status
Completed
Start date
July 1, 2023
Completion date
January 31, 2025
Enrollment
500 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

mody, type 1 diabetes